Oscar Health
OSCR
162 hedge funds and large institutions have $1.19B invested in Oscar Health in 2023 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 16 closing their positions.
306% more call options, than puts
Call options by funds: $6.19M | Put options by funds: $1.52M
175% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 16
74% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 34
24% more capital invested
Capital invested by funds: $965M → $1.19B (+$228M)
21% more funds holding
Funds holding: 134 → 162 (+28)
0.72% less ownership
Funds ownership: 81.5% → 80.78% (-0.72%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$11.2M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.85M |
| 3 |
BlackRock
New York
|
+$8.52M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$7.82M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Southeastern Asset Management
Memphis,
Tennessee
|
-$37M |
| 2 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
-$25.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$13.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.43M |
| 5 |
Millennium Management
New York
|
-$7.71M |
OSCR Hedge Fund Activity: Q2 2023 in Review
162 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q2 2023, worth a combined $1.19B — up 24% from $965M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new OSCR positions and 16 closed out — a net gain of 28 holders — while 59 added to existing stakes and 34 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $11.2M. The largest seller was Southeastern Asset Management, cutting an estimated $37M.
- 162 institutional investors held Oscar Health (OSCR) as of Q2 2023, up from 134 in Q1 2023.
- Funds reported $1.19B of Oscar Health stock for Q2 2023, up 24% quarter-over-quarter.
- 44 funds opened new Oscar Health positions in Q2 2023 and 16 closed out, a net change of +28 holders.
- The largest Oscar Health buyer in Q2 2023 was Renaissance Technologies, an estimated $11.2M added.
- The largest Oscar Health seller in Q2 2023 was Southeastern Asset Management, an estimated $37M sold.
Based on aggregated 13F filings for Q2 2023.